Important Update for Adults Living with NF1
Health Canada has approved Koselugo (selumetinib) for adults living with NF1 who have symptomatic and inoperable plexiform neurofibromas.
NF Symposium
Due to unforeseen circumstances, the NF Symposium 2026 has been cancelled. For any inquires, please contact us at info@tumourfoundation.ca
A Meaningful Step Forward for Adults Living with NF1
Health Canada has approved Koselugo (selumetinib) for adults living with NF1 who have symptomatic and inoperable plexiform neurofibromas.
Education Award Applications
NF should never stand in the way of opportunity. The next intake for applications closes April 30.
Charity Challenge
The Charity Challenge is an annual event where participants raise funds for local charities while running or walking a 5 km, half marathon, or participating virtually.